Article Listing - Vioxx costs see Merck & Co swing to $1.6B loss

NEW YORK MEETINGS

10 February 1992

Two industry-related meetings are due to be held soon at the Loews Summit Hotel, New York: Cost Containment and Quality...

FEMALE CONDOM RECOMMENDED FOR USA

10 February 1992

The Obstetrics and Gynec-ology Devices Advisory Commit-tee of the US Food and Drug Administration has recommended approval of Chartex Inter-national's...

EC "BLOW" TO NEW OTC PRODUCTS

10 February 1992

As it now stands, the Commission of the European Communities' proposed directive on advertising of over-the counter products in the...

"KEY" US PATENT FOR BIOPURE'S HEMOPURE

10 February 1992

Boston, Massachusetts-based start-up company Biopure Corp reports that it has received a US patent covering its novel blood substitute Hemopure,...

PFIZER PLANS NEW UNIT IN USA

10 February 1992

US pharmaceutical concern Pfizer is setting up a new unit at its Groton plant in the USA.The company has...

END OF FRENCH BLOC ON NEW DRUG INTROS

3 February 1992

The French government has agreed to renew the commission which gives advice to the Health Minister on drug-price fixing for...

RU's DIMETROSE FOR CYCLIC MASTALGIA

3 February 1992

A multicenter study investigating the applicability and safety of Roussel Uclaf's Dimetrose (gestrinone) as a treatment for women with cyclical...

WYETH AYERST/ TLC FLU VACCINE DEAL

3 February 1992

Wyeth-Ayerst Laboratories, a division of American Home Products, has entered into an agreement with The Liposome Company concerning the development...

STOCK MARKET COMMENTARY: TOKYO

3 February 1992

TOKYO: closed with a 0.4% gain at 21,007.11 yen after a volatile trading week dominated by index and futures- linked...

DU PONT'S JOHN KROL

3 February 1992

- John Krol has been named as a vice chairman and director of Du Pont Co.

Showing 94851-94860 of 95349 articles